PCSK9 and Alzheimer disease: We hypothesize that PCSK9, which we found to be increased in the CSF of AD patients [6], by degrading the neuronal apoE-recognizing receptors and possibly affecting other steps of the brain cholesterol transport, may reduce cholesterol supply to neurons, with potentially deleterious consequences for neuronal function and survival.